April 1st, 2020 – Kate Smith, from A.M. Best Review interviewed Bob Reville, CEO of Praedicat, on the shifting litigation landscape and the recent 4th party litigation on opioids. In…
read moreFilter posts by:
It has been an exciting ten weeks! As part of Cohort Three, Praedicat has developed Hundreds, the first named peril casualty product in Lloyd’s Lab. This was one of Lloyd’s of London key objectives for the Lab…
read moreMeg Green, A.M. Best interviews Bob Reville, CEO at Praedicat, about the Insurance Risk Hot List. In this interview, Bob Reville, offers insights on the possibility of mass litigation that…
read morehttps://vimeo.com/371151724 The countdown to Demo Day at Lloyd’s Lab has begun! It has been an amazing several weeks of innovation and collaboration. Praedicat looks forward to November 13th where we…
read morehttps://vimeo.com/305844252 ChemMeta helps businesses identify, track and manage emerging risks emanating from their ingredients and products in an unbiased and systematic way at “machine scale”. To learn more about Praedicat’s…
read moreYvette Essen, A.M. BestTV interviews Bob Reville, CEO at Praedicat, from Les Rendez-Vous de Septembre. In this interview, Bob Reville, offers insights on emerging risks and how insurers can use…
read moreUnderstanding emerging risk management is a primary concern for many advanced organizations. As the world’s first “Liability Cat” modeling company, Praedicat is changing the way organizations and insurance companies view…
read moreBob Reville, Praedicat’s CEO, is interviewed by Business Reporter. In the video interview, he describes Praedicat’s approach to emerging risk identification using a methodology based on peer-reviewed scientific literature and…
read more